- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19Q2 (20) | 22.43 | 0 | -12.59 | 2.8 | 0 | -9.97 | 1.34 | 0 | -15.72 | 0.66 | 0 | -4.35 | 12.48 | 2.35 | 3.0 | 5.97 | 8.76 | -3.59 | 2.94 | -29.87 | 9.43 | 1160 | 0 | -6.45 |
19Q1 (19) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 12.20 | 0.0 | 9.63 | 5.49 | 0.0 | 6.12 | 4.20 | 0.0 | 6.68 | 0 | -100.0 | 0 |
18Q4 (18) | 23.12 | 0 | -22.29 | 2.82 | 0 | -14.8 | 1.27 | 0 | -17.53 | 0.97 | 0 | -17.09 | 12.20 | 0.64 | 9.63 | 5.49 | -11.35 | 6.12 | 4.20 | 56.02 | 6.68 | 1160 | 0 | -10.77 |
18Q3 (17) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 12.12 | 0.0 | 15.53 | 6.20 | 0.0 | -12.11 | 2.69 | 0.0 | 19.62 | 0 | -100.0 | 0 |
18Q2 (16) | 25.66 | 0 | -12.6 | 3.11 | 0 | 0.97 | 1.59 | 0 | -23.19 | 0.69 | 0 | 4.55 | 12.12 | 8.93 | 15.53 | 6.20 | 19.7 | -12.11 | 2.69 | -31.63 | 19.62 | 1240 | 0 | -4.62 |
18Q1 (15) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 11.13 | 0.0 | 2.22 | 5.18 | 0.0 | -32.28 | 3.93 | 0.0 | 21.36 | 0 | -100.0 | 0 |
17Q4 (14) | 29.75 | 0 | 23.6 | 3.31 | 0 | 26.34 | 1.54 | 0 | -16.3 | 1.17 | 0 | 50.0 | 11.13 | 6.06 | 2.22 | 5.18 | -26.58 | -32.28 | 3.93 | 74.95 | 21.36 | 1300 | 0 | 0.0 |
17Q3 (13) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 10.49 | 0.0 | -10.33 | 7.05 | 0.0 | 3.75 | 2.25 | 0.0 | -29.85 | 0 | -100.0 | 0 |
17Q2 (12) | 29.36 | 0 | 13.36 | 3.08 | 0 | 1.65 | 2.07 | 0 | 17.61 | 0.66 | 0 | -20.48 | 10.49 | -3.62 | -10.33 | 7.05 | -7.77 | 3.75 | 2.25 | -30.63 | -29.85 | 1300 | 0 | -1.52 |
17Q1 (11) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 10.88 | 0.0 | -14.07 | 7.64 | 0.0 | -26.86 | 3.24 | 0.0 | 0.67 | 0 | -100.0 | 0 |
16Q4 (10) | 24.07 | 0 | 0.63 | 2.62 | 0 | -13.53 | 1.84 | 0 | -26.4 | 0.78 | 0 | 1.3 | 10.88 | -6.96 | -14.07 | 7.64 | 12.49 | -26.86 | 3.24 | 1.12 | 0.67 | 1300 | 0 | -1.52 |
16Q3 (9) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 11.70 | 0.0 | -3.3 | 6.80 | 0.0 | 3.92 | 3.20 | 0.0 | -3.71 | 0 | -100.0 | 0 |
16Q2 (8) | 25.9 | 0 | 1.41 | 3.03 | 0 | -1.94 | 1.76 | 0 | 5.39 | 0.83 | 0 | -2.35 | 11.70 | -7.64 | -3.3 | 6.80 | -34.98 | 3.92 | 3.20 | -0.45 | -3.71 | 1320 | 0 | -5.71 |
16Q1 (7) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 12.67 | 0.0 | 24.59 | 10.45 | 0.0 | 103.2 | 3.22 | 0.0 | 8.73 | 0 | -100.0 | 0 |
15Q4 (6) | 23.92 | 0 | -28.47 | 3.03 | 0 | -10.88 | 2.5 | 0 | 45.35 | 0.77 | 0 | -22.22 | 12.67 | 4.7 | 24.59 | 10.45 | 59.84 | 103.2 | 3.22 | -3.28 | 8.73 | 1320 | 0 | -5.71 |
15Q3 (5) | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 12.10 | 0.0 | 0 | 6.54 | 0.0 | 0 | 3.33 | 0.0 | 0 | 0 | -100.0 | 0 |
15Q2 (4) | 25.54 | 0 | 0.0 | 3.09 | 0 | 0.0 | 1.67 | 0 | 0.0 | 0.85 | 0 | 0.0 | 12.10 | 18.99 | 0.0 | 6.54 | 27.13 | 0.0 | 3.33 | 12.42 | 0.0 | 1400 | 0 | 0.0 |
15Q1 (3) | 0 | -100.0 | 0.0 | 0 | -100.0 | 0.0 | 0 | -100.0 | 0.0 | 0 | -100.0 | 0.0 | 10.17 | 0.0 | 0.0 | 5.14 | 0.0 | 0.0 | 2.96 | 0.0 | 0.0 | 0 | -100.0 | 0.0 |
14Q4 (2) | 33.44 | 0 | 0.0 | 3.4 | 0 | 0.0 | 1.72 | 0 | 0.0 | 0.99 | 0 | 0.0 | 10.17 | 0 | 0.0 | 5.14 | 0 | 0.0 | 2.96 | 0 | 0.0 | 1400 | 0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 (10) | 38.24 | -2.7 | 4.14 | -21.29 | 2.51 | -18.77 | 1.21 | -3.97 | 10.83 | -19.11 | 6.56 | -16.52 | 3.16 | -1.31 | 1160 | 0.0 |
2019 (9) | 39.3 | -19.43 | 5.26 | -11.3 | 3.09 | 7.67 | 1.26 | -24.1 | 13.38 | 10.1 | 7.86 | 33.64 | 3.21 | -5.79 | 1160 | 0.0 |
2018 (8) | 48.78 | -17.48 | 5.93 | -7.2 | 2.87 | -20.5 | 1.66 | -9.29 | 12.16 | 12.45 | 5.88 | -3.66 | 3.40 | 9.92 | 1160 | -6.45 |
2017 (7) | 59.11 | 18.29 | 6.39 | 13.1 | 3.61 | 0.28 | 1.83 | 14.37 | 10.81 | -4.39 | 6.11 | -15.23 | 3.10 | -3.31 | 1240 | -4.62 |
2016 (6) | 49.97 | 1.03 | 5.65 | -7.68 | 3.6 | -13.67 | 1.6 | -1.23 | 11.31 | -8.62 | 7.20 | -14.55 | 3.20 | -2.24 | 1300 | -1.52 |
2015 (5) | 49.46 | -25.29 | 6.12 | -7.13 | 4.17 | 30.31 | 1.62 | -13.37 | 12.37 | 24.3 | 8.43 | 74.42 | 3.28 | 15.95 | 1320 | -5.71 |
2014 (4) | 66.2 | -0.33 | 6.59 | -9.23 | 3.2 | 46.79 | 1.87 | -8.78 | 9.95 | -8.93 | 4.83 | 47.28 | 2.82 | -8.48 | 1400 | 0.0 |
2013 (3) | 66.42 | -7.52 | 7.26 | 5.22 | 2.18 | -25.85 | 2.05 | -12.02 | 10.93 | 13.77 | 3.28 | -19.82 | 3.09 | -4.86 | 1400 | -12.5 |
2012 (2) | 71.82 | -20.75 | 6.9 | 0 | 2.94 | 0 | 2.33 | 0 | 9.61 | 0 | 4.09 | 0 | 3.24 | 0 | 1600 | -15.79 |
2011 (1) | 90.63 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 1900 | 0 |